Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × ProMune × Clear all

NCT00490529 2020-01-13

Phase 1-2 of a CpG-Activated Whole Cell Vaccine Followed by Autologous Immunotransplant for MCL

Phase 2 Completed

59 enrolled 14 charts

Lymphoma, Mantle-Cell